Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme

With the emergence and global spread of the COVID-19 pandemic, the scientific community worldwide has focused on search for new therapeutic strategies against this disease. One such critical approach is targeting proteins such as helicases that regulate most of the SARS-CoV-2 RNA metabolism. The pur...

Full description

Bibliographic Details
Main Authors: Sajjad Ahmad, Yasir Waheed, Saba Ismail, Saadia Bhatti, Sumra Wajid Abbasi, Khalid Muhammad
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/5/1446
_version_ 1797412615932084224
author Sajjad Ahmad
Yasir Waheed
Saba Ismail
Saadia Bhatti
Sumra Wajid Abbasi
Khalid Muhammad
author_facet Sajjad Ahmad
Yasir Waheed
Saba Ismail
Saadia Bhatti
Sumra Wajid Abbasi
Khalid Muhammad
author_sort Sajjad Ahmad
collection DOAJ
description With the emergence and global spread of the COVID-19 pandemic, the scientific community worldwide has focused on search for new therapeutic strategies against this disease. One such critical approach is targeting proteins such as helicases that regulate most of the SARS-CoV-2 RNA metabolism. The purpose of the current study was to predict a library of phytochemicals derived from diverse plant families with high binding affinity to SARS-CoV-2 helicase (Nsp13) enzyme. High throughput virtual screening of the Medicinal Plant Database for Drug Design (MPD3) database was performed on SARS-CoV-2 helicase using AutoDock Vina. Nilotinib, with a docking value of −9.6 kcal/mol, was chosen as a reference molecule. A compound (PubChem CID: 110143421, ZINC database ID: ZINC257223845, eMolecules: 43290531) was screened as the best binder (binding energy of −10.2 kcal/mol on average) to the enzyme by using repeated docking runs in the screening process. On inspection, the compound was disclosed to show different binding sites of the triangular pockets collectively formed by Rec1A, Rec2A, and 1B domains and a stalk domain at the base. The molecule is often bound to the ATP binding site (referred to as binding site 2) of the helicase enzyme. The compound was further discovered to fulfill drug-likeness and lead-likeness criteria, have good physicochemical and pharmacokinetics properties, and to be non-toxic. Molecular dynamic simulation analysis of the control/lead compound complexes demonstrated the formation of stable complexes with good intermolecular binding affinity. Lastly, affirmation of the docking simulation studies was accomplished by estimating the binding free energy by MMPB/GBSA technique. Taken together, these findings present further in silco investigation of plant-derived lead compounds to effectively address COVID-19.
first_indexed 2024-03-09T05:05:43Z
format Article
id doaj.art-1ad3e37dafbb4eb1a785e8bc8d010edf
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T05:05:43Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-1ad3e37dafbb4eb1a785e8bc8d010edf2023-12-03T12:54:49ZengMDPI AGMolecules1420-30492021-03-01265144610.3390/molecules26051446Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase EnzymeSajjad Ahmad0Yasir Waheed1Saba Ismail2Saadia Bhatti3Sumra Wajid Abbasi4Khalid Muhammad5Foundation University Medical College, Foundation University Islamabad, DHA-I, Islamabad 44000, PakistanFoundation University Medical College, Foundation University Islamabad, DHA-I, Islamabad 44000, PakistanFoundation University Medical College, Foundation University Islamabad, DHA-I, Islamabad 44000, PakistanDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad 44000, PakistanNUMS Department of Biological Sciences, National University of Medical Sciences, Abid Majeed Rd, The Mall, Rawalpindi 46000, PakistanDepartment of Biology, College of Science, United Arab Emirates University, Al Ain 15551, United Arab EmiratesWith the emergence and global spread of the COVID-19 pandemic, the scientific community worldwide has focused on search for new therapeutic strategies against this disease. One such critical approach is targeting proteins such as helicases that regulate most of the SARS-CoV-2 RNA metabolism. The purpose of the current study was to predict a library of phytochemicals derived from diverse plant families with high binding affinity to SARS-CoV-2 helicase (Nsp13) enzyme. High throughput virtual screening of the Medicinal Plant Database for Drug Design (MPD3) database was performed on SARS-CoV-2 helicase using AutoDock Vina. Nilotinib, with a docking value of −9.6 kcal/mol, was chosen as a reference molecule. A compound (PubChem CID: 110143421, ZINC database ID: ZINC257223845, eMolecules: 43290531) was screened as the best binder (binding energy of −10.2 kcal/mol on average) to the enzyme by using repeated docking runs in the screening process. On inspection, the compound was disclosed to show different binding sites of the triangular pockets collectively formed by Rec1A, Rec2A, and 1B domains and a stalk domain at the base. The molecule is often bound to the ATP binding site (referred to as binding site 2) of the helicase enzyme. The compound was further discovered to fulfill drug-likeness and lead-likeness criteria, have good physicochemical and pharmacokinetics properties, and to be non-toxic. Molecular dynamic simulation analysis of the control/lead compound complexes demonstrated the formation of stable complexes with good intermolecular binding affinity. Lastly, affirmation of the docking simulation studies was accomplished by estimating the binding free energy by MMPB/GBSA technique. Taken together, these findings present further in silco investigation of plant-derived lead compounds to effectively address COVID-19.https://www.mdpi.com/1420-3049/26/5/1446SARS-CoV-2 helicaseCOVID-19molecular dynamic simulationphytochemicals
spellingShingle Sajjad Ahmad
Yasir Waheed
Saba Ismail
Saadia Bhatti
Sumra Wajid Abbasi
Khalid Muhammad
Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
Molecules
SARS-CoV-2 helicase
COVID-19
molecular dynamic simulation
phytochemicals
title Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
title_full Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
title_fullStr Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
title_full_unstemmed Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
title_short Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme
title_sort structure based virtual screening identifies multiple stable binding sites at the reca domains of sars cov 2 helicase enzyme
topic SARS-CoV-2 helicase
COVID-19
molecular dynamic simulation
phytochemicals
url https://www.mdpi.com/1420-3049/26/5/1446
work_keys_str_mv AT sajjadahmad structurebasedvirtualscreeningidentifiesmultiplestablebindingsitesattherecadomainsofsarscov2helicaseenzyme
AT yasirwaheed structurebasedvirtualscreeningidentifiesmultiplestablebindingsitesattherecadomainsofsarscov2helicaseenzyme
AT sabaismail structurebasedvirtualscreeningidentifiesmultiplestablebindingsitesattherecadomainsofsarscov2helicaseenzyme
AT saadiabhatti structurebasedvirtualscreeningidentifiesmultiplestablebindingsitesattherecadomainsofsarscov2helicaseenzyme
AT sumrawajidabbasi structurebasedvirtualscreeningidentifiesmultiplestablebindingsitesattherecadomainsofsarscov2helicaseenzyme
AT khalidmuhammad structurebasedvirtualscreeningidentifiesmultiplestablebindingsitesattherecadomainsofsarscov2helicaseenzyme